Carregant...
EXTH-79. INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 FOR RECURRENT GLIOBLASTOMA
INTRODUCTION: CUSP9v3/v4 uses 9 re-purposed drugs having preclinical data indicating antiglioma effects. We offered compassionate-use CUSP9v3 to 7, CUSP9v4 to 1, heavily pretreated low Karnofsky Performance Score patients with recurrent glioblastoma. CUSP9v3 uses aprepitant, a neurokinin-1 receptor...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692299/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.369 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|